[ad_1]
Rugilė Pilvinienė, Senior Advisor to IWT’s Department of Pharmacovigilance and Poison Information, told LRT Radio on Wednesday that “the process is likely not to be completed tomorrow as there are several additional options possible from a procedural point of view.”
“It may be that the EVA will take some other step: seek the advice of a scientific group or start another procedure, it is likely that the final conclusion will not be reached,” said R. Pilvinienė.
He also said there had been another report of a severe reaction in the country Tuesday night after the AstraZaneca vaccination, but said he was not yet fully aware of the information because it was “very recent.”
In Lithuania a total of four such reports were received, three were treated in hospitals and one was discharged for treatment at home. The Office stresses that the link between the case reports and the vaccines received has not yet been established or confirmed.
On Tuesday, Health Minister Arūnas Dulkys temporarily suspended vaccination with AstraZeneca against the coronavirus, taking into account the IWT recommendation.
After receiving three reports of thromboembolic events, the IARC recommended that vaccination with AstraZeneca be discontinued until the European Medicines Agency has issued final conclusions on the safety of the vaccine. The European Medicines Agency (EMA) is convening a meeting on the vaccine on Thursday. On Tuesday, Minister A. Dulkys said he expected the EEA conclusion to be presented on Thursday.
[ad_2]
